BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 619025)

  • 1. Brain monoamine metabolites and tryptophan in ventricular CSF of patients with spasm after aneurysm surgery.
    Vapalahti M; Hyyppä MT; Nieminen V; Rinne UK
    J Neurosurg; 1978 Jan; 48(1):58-63. PubMed ID: 619025
    [No Abstract]   [Full Text] [Related]  

  • 2. Tryptophan and monoamine metabolites in ventricular cerebrospinal fluid after severe cerebral trauma.
    Hyyppä MT; Långvik VA; Nieminen V; Vapalahti M
    Lancet; 1977 Jun; 1(8026):1367-8. PubMed ID: 69086
    [No Abstract]   [Full Text] [Related]  

  • 3. Monoamine acid metabolites in ventricular CSF of patients with brain tumours.
    Bareggi SR; Porta M; Collice M; Calderini G; Ferrara M; Morselli PL
    Acta Neurochir (Wien); 1976; 35(1-3):161-70. PubMed ID: 961500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parallel variation of homovanillic acid, 5-hydroxyindoleacetic acid and cyclic adenosine-3, 5-monophosphate in ventricular cerebrospinal fluid of man.
    Inagawa T
    Hiroshima J Med Sci; 1982 Jun; 31(2):117-21. PubMed ID: 6182129
    [No Abstract]   [Full Text] [Related]  

  • 5. Monoamine metabolites and ventricular fluid pressure in children.
    Yates CM; Minns RA
    Childs Brain; 1981; 8(2):138-44. PubMed ID: 6166434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies.
    Garelis E; Young SN; Lal S; Sourkes TL
    Brain Res; 1974 Oct; 79(1):1-8. PubMed ID: 4279131
    [No Abstract]   [Full Text] [Related]  

  • 7. Transmitter precursors and metabolites in human ventricular cerebrospinal fluid.
    Curzon G; Kantamaneni BD; Bartlett JR; Bridges PK
    J Neurochem; 1976 Mar; 26(3):613-5. PubMed ID: 4585
    [No Abstract]   [Full Text] [Related]  

  • 8. Determination of HVA and 5-HIAA in ventricular CSF of patients with brain tumors.
    Porta M; Bareggi SR; Collice M; Ferrara M; Calderini G; Morselli PL
    J Neurosurg Sci; 1974; 18(3):157-63. PubMed ID: 4465414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amine metabolites in the ventricular cerebrospinal fluid of patients with ventricular dilatation. HPLC and clinical application (IV).
    Ikeda Y; Nakazawa S
    Nihon Ika Daigaku Zasshi; 1982; 49(6):848-50. PubMed ID: 6187766
    [No Abstract]   [Full Text] [Related]  

  • 10. 5-Hydroxyindoleacetic acid, homovanillic acid and tryptophan levels in CSF above and below a complete block of CSF flow.
    Young SN; Lal S; Martin JB; Ford RM; Sourkes TL
    Psychiatr Neurol Neurochir; 1973; 76(6):439-44. PubMed ID: 4781523
    [No Abstract]   [Full Text] [Related]  

  • 11. Monoamine metabolites in ventricular and lumbar CSF of patients with brain tumors. HPLC and clinical application (II).
    Ikeda Y; Nakazawa S
    Nihon Ika Daigaku Zasshi; 1981 Oct; 48(5):704-7. PubMed ID: 6175655
    [No Abstract]   [Full Text] [Related]  

  • 12. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M
    Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precursors and metabolites of 5-hydroxytryptamine and dopamine in the ventricular cerebrospinal fluid of psychiatric patients.
    Bridges PK; Bartlett JR; Sepping P; Kantamaneni BD; Curzon G
    Psychol Med; 1976 Aug; 6(3):399-405. PubMed ID: 996200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of monoamine metabolites and of tryptophan in the basal cisternal CSF of patients after subarachnoid haemorrhage.
    Suzuki Y; Ogura K; Shibuya M; Okada T; Kageyama N; Yamamoto I; Hara M
    Acta Neurochir (Wien); 1987; 87(1-2):58-62. PubMed ID: 2445175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Values of serial determinations of cerebrospinal fluid metabolites of biogenic amines in various neurologic diseases].
    Spissu A; Piccardi MP; Corsini GU; Mangoni A
    Acta Neurol (Napoli); 1976; 31(5):549-57. PubMed ID: 827925
    [No Abstract]   [Full Text] [Related]  

  • 16. Concentration of 5-hydroxyindoleacetic acid, homovanillic acid, and tryptophan in the cerebrospinal fluid of depressed patients before and after ECT.
    Abrams R; Essman WB; Taylor MA; Fink M
    Biol Psychiatry; 1976 Feb; 11(1):85-90. PubMed ID: 1260078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentration of homovanillic acid and 5-hydroxyindoleacetic acid in the ventricular cerebrospinal fluid of patients with obstructive hydrocephalus.
    Kmieciak-Kolada K; Majchrzak H; Herman ZS
    J Neurol Neurosurg Psychiatry; 1979 Jan; 42(1):78-81. PubMed ID: 216782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sites of origin in the central nervous system of monoamine metabolites measured in human cerebrospinal fluid.
    Garelis E; Sourkes TL
    J Neurol Neurosurg Psychiatry; 1973 Aug; 36(4):625-9. PubMed ID: 4731331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical investigations in Parkinsonism. A study of the metabolites of the biogenic amines in the lumbar CSF.
    Pullar IA; Dowson JH; Ahmed R; Chow R; Gillingham FJ
    Confin Neurol; 1972; 34(2):143-8. PubMed ID: 4666057
    [No Abstract]   [Full Text] [Related]  

  • 20. Monoamine metabolites in the CSF of conscious unrestrained cats.
    Degrell I; Zenner K; Kummer P; Stock G
    Brain Res; 1983 Oct; 277(2):283-7. PubMed ID: 6196083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.